Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells

Journal of Biochemistry

Volumn 144, Issue 5, 2008, Pages 685-690

  Wang, Jun ^a,b   Zhao, Li Ying ^a,c   Uyama, Toru ^a   Tsuboi, Kazuhito ^a   Wu, Xiu Xian ^a   Kakehi, Yoshiyuki ^a   Ueda, Natsuo ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b First Affiliated Hospital   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Anandamide; Endocannabinoid; LNCaP cell; Lysosomal enzyme; N acylethanolamine

Indexed keywords

AMIDASE; ANANDAMIDE; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; ENDOCANNABINOID; ETHANOLAMINE; FATTY ACID AMIDASE; N ACYLETHANOLAMINE HYDROLYSING ACID AMIDASE; N ACYLPHOSPHATIDYLETHANOLAMINE HYDROLYSING PHOSPHOLIPASE D; PALMIDROL; PHOSPHOLIPASE D; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ACTIVE SITE; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HYDROLYSIS; LYSOSOME; MALE; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN SECRETION;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; CELL LINE, TUMOR; ENDOCANNABINOIDS; ETHANOLAMINES; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; POLYUNSATURATED ALKAMIDES; PROSTATIC NEOPLASMS; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 55349108909     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvn122     Document Type: Article

References (38)

1. Pacher, P., Bátkai, S., and Kunos, G. (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58, 389-462
2. Lambert, D.M., Vandevoorde, S., Jonsson, K.-O., and Fowler, C.J. (2002) The palmitoylethanolamide family: a new class of anti-inflammatory agents? Curr. Med. Chem. 9, 663-674
3. Wang, J. and Ueda, N. (2008) Role of the endocannabinoid system in metabolic control. Curr. Opin. Nephrol. Hypertens. 17, 1-10
4. Tsuboi, K., Takezaki, N., and Ueda, N. (2007) The N-acylethanolamine-hydrolyzing acid amidase (NAAA). Chem. Biodivers. 4, 1914-1925
5. McKinney, M.K. and Cravatt, B.F. (2005) Structure and function of fatty acid amide hydrolase. Annu. Rev. Biochem. 74, 411-432
6. Ueda, N., Yamanaka, K., Terasawa, Y., and Yamamoto, S. (1999) An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors. FEBS Lett. 454, 267-270
7. Sun, Y.-X., Tsuboi, K., Zhao, L.-Y., Okamoto, Y., Lambert, D.M., and Ueda, N. (2005) Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. Biochim. Biophys. Acta 1736, 211-220
8. Ueda, N., Yamamoto, K., Yamamoto, S., Tokunaga, T., Shirakawa, E., Shinkai, H., Ogawa, M., Sato, T., Kudo, I., Inoue, K., Takizawa, H., Nagano, T., Hirobe, M., Matsuki, N., and Saito, H. (1995) Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist. Biochim. Biophys. Acta 1254, 127-134
9. Tsuboi, K., Zhao, L.-Y., Okamoto, Y., Araki, N., Ueno, M., Sakamoto, H., and Ueda, N. (2007) Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies. Biochim. Biophys. Acta 1771, 623-632
10. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
11. Zhao, L.-Y., Tsuboi, K., Okamoto, Y., Nagahata, S., and Ueda, N. (2007) Proteolytic activation and glycosylation of N-acylethanolamine- hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism. Biochim. Biophys. Acta 1771, 1397-1405
12. Cravatt, B.F., Giang, D.K., Mayfield, S.P., Boger, D.L., Lerner, R.A., and Gilula, N.B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty acid amides. Nature 384, 83-87
13. Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., and Ueda, N. (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279, 5298-5305
14. Wang, J., Okamoto, Y., Morishita, J., Tsuboi, K., Miyatake, A., and Ueda, N. (2006) Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-β-lactamase family. J. Biol. Chem. 281, 12325-12335
15. Tsuboi, K., Sun, Y.-X., Okamoto, Y., Araki, N., Tonai, T., and Ueda, N. (2005) Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J. Biol. Chem. 280, 11082-11092
16. Ueda, N., Kurahashi, Y., Yamamoto, S., and Tokunaga, T. (1995) Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chem. 270, 23823-23827
17. Ueda, N., Yamanaka, K., and Yamamoto, S. (2001) Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous antiinflammatory substance. J. Biol. Chem. 276, 35552-35557
18. Ferlinz, K., Kopal, G., Bernardo, K., Linke, T., Bär, J., Breiden, B., Neumann, U., Lang, F., Schuchman, E.H., and Sandhoff, K. (2001) Human acid ceramidase: processing, glycosylation, and lysosomal targeting. J. Biol. Chem. 276, 35352-35360
19. Probst, O.C., Ton, P., Svoboda, B., Gannon, A., Schuhmann, W., Wieser, J., Pohlmann, R., and Mach, L. (2006) The 46-kDa mannose 6-phosphate receptor does not depend on endosomal acidification for delivery of hydrolases to lysosomes. J. Cell Sci. 119, 4935-4943
20. Hong, S.-B., Li, C.-M., Rhee, H.-J., Park, J.-H., He, X., Levy, B., Yoo, O.J., and Schuchman, E.H. (1999) Molecular cloning and characterization of a human cDNA and gene encoding a novel acid ceramidase-like protein. Genomics 62, 232-241
21. Endsley, M.P., Thill, R., Choudhry, I., Williams, C.L., Kajdacsy-Balla, A., Campbell, W.B., and Nithipatikom, K. (2008) Expression and function of fatty acid amide hydrolase in prostate cancer. Int. J. Cancer 123, 1318-1326
22. Ruiz-Llorente, L., Ortega-Gutiérrez, S., Viso, A., Sánchez, M.G., Sánchez, A.M., Fernández, C., Ramos, J.A., Hillard, C., Lasunción, M.A., López-Rodríguez, M.L., and Díaz-Laviada, I. (2004) Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study. Br. J. Pharmacol. 141, 457-467
23. 1 in the human prostate gland. Prostate 54, 95-102
24. Melck, D., De Petrocellis, L., Orlando, P., Bisogno, T., Laezza, C., Bifulco, M., and Di Marzo, V. (2000) Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 141, 118-126
25. Schuel, H., Burkman, L.J., Lippes, J., Crickard, K., Forester, E., Piomelli, D., and Giuffrida, A. (2002) N-Acylethanolamines in human reproductive fluids. Chem. Phys. Lipids 121, 211-227
26. Veltri, R. and Rodriguez, R. (2007) Molecular biology, endocrinology, and physiology of the prostate and seminal vesicles in Campbel-Walsh Urology (Wein, A.J., Kavoussi, L.R., Novick, A.C., Partin, A.W., and Peters, C.A., eds.), pp. 2677-2726, Elsevier, Philadelphia, PA
27. Bifulco, M., Laezza, C., Gazzerro, P., and Pentimalli, F. (2007) Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion. Oncol. Rep. 17, 813-816
28. Mimeault, M., Pommery, N., Wattez, N., Bailly, C., and Hénichart, J.-P. (2003) Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production. Prostate 56, 1-12
29. Sánchez, M.G., Sánchez, A.M., Ruiz-Llorente, L., and Díaz-Laviada, I. (2003) Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells. FEBS Lett. 555, 561-566
30. Eto, M., Bennouna, J., Hunter, O.C., Lotze, M.T., and Amoscato, A.A. (2006) Importance of C16 ceramide accumulation during apoptosis in prostate cancer cells. Int. J. Urol. 13, 148-156
31. De Petrocellis, L., Bisogno, T., Ligresti, A., Bifulco, M., Melck, D., and Di Marzo, V. (2002) Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems. Fundam. Clin. Pharmacol. 16, 297-302
32. Maccarrone, M., Pauselli, R., Di Rienzo, M., and Finazzi-Agrò, A. (2002) Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells. Biochem. J. 366, 137-144
33. Isaacs, J.T. (1999) The biology of hormone refractory prostate cancer. Why does it develop? Urol. Clin. North Am. 26, 263-273
34. Tappel, A. (2005) Lysosomal and prostasomal hydrolytic enzymes and redox processes and initiation of prostate cancer. Med. Hypotheses 64, 1170-1172
35. Nomura, T. and Katunuma, N. (2005) Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J. Med. Invest. 52, 1-9
36. Lilja, H., Ulmert, D., and Vickers, A.J. (2008) Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat. Rev. Cancer 8, 268-278
37. Bradford, T.J., Tomlins, S.A., Wang, X., and Chinnaiyan, A.M. (2006) Molecular markers of prostate cancer. Urol. Oncol. 24, 538-551
38. Parekh, D.J., Ankerst, D.P., Troyer, D., Srivastava, S., and Thompson, I.M. (2007) Biomarkers for prostate cancer detection. J. Urol. 178, 2252-2259